<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: The aim of the study was to assess the efficacy of lumboperitoneal flow-regulated shunt for the treatment of idiopathic intracranial <z:hpo ids='HP_0000822'>hypertension</z:hpo> (IIH) </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: This was a retrospective study carried out on four patients with IIH, treated from January to December 2007 with lumboperitoneal flow-regulated shunt (OSV II Smart Valve Systems; Integra NeuroSciences) </plain></SENT>
<SENT sid="2" pm="."><plain>The mean follow-up period was 13 months </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: The treatment was successful in alleviating symptoms in <z:hpo ids='HP_0000001'>all</z:hpo> cases and no patient required revisions </plain></SENT>
<SENT sid="4" pm="."><plain>CONCLUSIONS: In conclusion the placement of flow-regulated valves is a satisfactory treatment for those IIH patients who require surgical therapy </plain></SENT>
</text></document>